The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
11.42
-0.19 (-1.64%)
At close: Jun 27, 2025, 4:00 PM
11.84
+0.42 (3.68%)
After-hours: Jun 27, 2025, 4:43 PM EDT
The Joint Revenue
The Joint had revenue of $13.08M in the quarter ending March 31, 2025, with 7.33% growth. This brings the company's revenue in the last twelve months to $52.79M, up 71.05% year-over-year. In the year 2024, The Joint had annual revenue of $51.90M with 10.47% growth.
Revenue (ttm)
$52.79M
Revenue Growth
+71.05%
P/S Ratio
3.13
Revenue / Employee
$71,725
Employees
736
Market Cap
174.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51.90M | 4.92M | 10.47% |
| Dec 31, 2023 | 46.98M | -54.27M | -53.60% |
| Dec 31, 2022 | 101.25M | 21.24M | 26.55% |
| Dec 31, 2021 | 80.01M | 21.33M | 36.34% |
| Dec 31, 2020 | 58.68M | 10.23M | 21.12% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
JYNT News
- 3 days ago - The Joint Corp. Signs Binding Agreement to Sell 31 Corporate Clinics in Arizona and New Mexico and to Acquire Regional Developer Rights in the Northwest Region and Refranchises Five Corporate Clinics in the Kansas City Region, Tracking to Become Largest Pure Play Chiropractic Care Franchise System - GlobeNewsWire
- 17 days ago - The Joint Corp. Names Business Transformation and Growth Expert Scott J. Bowman Chief Financial Officer - GlobeNewsWire
- 23 days ago - The Joint Corp. Announces $5 Million Stock Repurchase Program - GlobeNewsWire
- 24 days ago - The Joint Corp. Appoints Sandi Karrmann as Director - GlobeNewsWire
- 5 weeks ago - The Joint Corp. Announces Christopher M. Grandpre Elected as Director - GlobeNewsWire
- 6 weeks ago - The Joint Corp. (JYNT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - The Joint Corp. to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - The Joint Corp. Strengthens Management Appointing SVP Legal and SVP Operations and Patient Experience - GlobeNewsWire